COVID-19 in Healthcare Professionals: Evaluation of Clinical, Demographic and Laboratory Results

Yıl 2022, , 598 - 593, 27.12.2022

Mehmet Çelik , Mehmet Reşat Ceylan , Çiğdem Cindoğlu , Leyla Yılmaz , Gülsüm Kökten

https://doi.org/10.35440/hutfd.1185749

Cited By: 1

Öz

Background: In this study, it was aimed to present the clinical symptoms, vaccination status, demographic and laboratory data of the healthcare workers diagnosed with COVID-19 in our hospital.
Materials and methods: Healthcare workers diagnosed with COVID-19 between April 2020 and August 2021 were included in the study.
Results: A total of 490 healthcare workers, 320 male (65.30%) and 170 female (34.70%), were included in the study. The mean age of all patients was 32.70±8.77 years. During the date of the study, 33% of healthcare workers were diagnosed with COVID-19. The most frequently diagnosed occupational groups were nurses (39.18%) and doctors (19.79%). It was observed that 9.39% of the employees were asymptomatic and 4.08% were in the high-risk group of COVID-19. The most common symptoms were fatigue (71.84%), high fever (70.27%) and cough (69.05%). 9.59% of the patients were hospitalized and followed up. In 54.05% of these patients, there was infiltration compatible with COVID-19 in the thorax computed tomography. The most common findings in laboratory examinations are; LDH (28.95%) and CRP (27.78%) were elevated.
Conclusion: Healthcare workers are in the high risk group because of their close contact with patients during the pandemic process. In the study, it is seen that one out of every three healthcare workers is infected with the virus, which is a very high rate. The fact that only 4.08% of the employees diagnosed with COVID-19 are in the high risk group of COVID-19 shows how important the use of personal protective equipment is.

Anahtar Kelimeler

COVID-19, Healthcare workers, SARS-CoV-2

Sağlık Çalışanlarında COVID-19: Klinik, Demografik ve Laboratuvar Sonuçlarının Değerlendirilmesi

Öz

Amaç: Bu çalışmada hastanemizde görevli sağlık çalışanlarından COVID-19 tanısı alanların klinik semptomları, aşılanma durumları, demografik ve laboratuvar verilerinin sunulması amaçlandı.
Materyal ve Metod: Nisan 2020-Ağustos 2021 tarihleri arasında COVID-19 tanısı alan sağlık çalışanları çalışmaya dahil edildi.
Bulgular: Çalışmaya 320 erkek (%65.30) ve 170 kadın (%34.70) olmak üzere 490 sağlık çalışanı dahil edildi. Tüm hastaların yaş ortalaması 32.70±8.77 yıldı. Çalışmanın yapıldığı tarih aralığında sağlık çalışanlarının %33’ü COVID-19 tanısı aldı. En fazla tanı alan meslek grupları hemşireler (%39.18) ve doktorlardı (%19.79). Çalışanların %9.39’u asemptomatik ve %4.08’inin COVID-19 yüksek riskli grupta yer aldığı görüldü. En sık görülen semptomlar; halsizlik (%71.84), yüksek ateş (%70.27) ve öksürüktü (%69.05). Hastaların %9.59’u yatırılarak takip edildi. Bu hastaların %54.05’’inde akciğer bilgisayarlı tomografisinde COVID-19 ile uyumlu infiltrasyon vardı. Laboratuvar tetkiklerinde en sık saptanan bulgular; LDH (%28.95) ve CRP (%27.78) yükseklikleri idi.
Sonuç: Sağlık çalışanları pandemi sürecinde hastalarla yakın temasları nedeniyle yüksek risk grubunda yer almaktadırlar. Çalışmada her üç sağlık çalışanından birinin virüs ile enfekte olduğu görülmektedir ve oldukça yüksek bir orandır. COVID-19 tanısı alan çalışanların sadece %4.08’inin COVID-19 yüksek riskli grupta yer alması kişisel koruyucu ekipman kullanımının ne kadar önemli olduğunu göstermektedir.

Anahtar Kelimeler

COVID-19, Sağlık çalışanları, SARS-CoV-2

Kaynakça

• 1. World Health Organization [Internet]. The impact of COVID-19 on health and care workers:a closer look at deaths [Accessed 6 October 2022]. Available from: https://apps.who.int/iris/handle/10665/345300. License: CC BY-NC-SA 3.0 IGO.
• 2. World Health Organization [Internet]. WHO Director-General’s opening remarks at the media briefing on COVID-19-11 March 2020 [Accessed 6 October 2022]. Available from: https://www.who.int/dg/speeches/detail/who-director-general-s-opening remarks- at- the- media- briefing- on- COVID-19-11-march- 2020.
• 3. T.C. Sağlık Bakanlığı. Halk Sağlığı Genel Müdürlüğü [Internet]. COVID-19 (SARS-CoV-2 enfeksiyonu) genel bilgiler, epidemiyoloji ve tanı. [Erişim tarihi 6 Ekim 2022, Güncel tarih 07.12.2020]. URL: https://covid19.saglik.gov.tr/TR-66337/genel-bilgiler-epidemiyoloji-ve-tani.html
• 4. Rabi FA, Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS-CoV-2 and coronavirus disease 2019: What we know so far. Pathogens. 2020; 9(3):231.
• 5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506.
• 6. World Health Organization [Internet]. Health workforce policy and management in the context of the COVID-19 pandemic response: interim guidance. Geneva: World Health Organization; 2020 [Accessed 6 October 2022]. Available from: https://apps.who.int/iris/handle/10665/337333.
• 7. Sommerstein R, Fux CA, Vuichard-Gysin D, Abbas M, Marschall J, Balmelli C, et al. Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19. Antimicrob Re¬sist Infect Control. 2020; 9(1):100.
• 8. Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020; 382(10):970-971.
• 9. Eren E, Çelik İ, Yıldız M, Topaloglu US, Kilinc-Toker A, Arman-Firat E, et al. Evaluation of health care workers with COVID-19. Klimik Derg. 2020; 33(3):230-4.
• 10. World Health Organization [Internet]. Health and Care Worker Deaths during COVID-19 [Accessed 6 October 2022]. Available from: https://www.who.int/news/item/20-10-2021-health-and-care-worker-deaths-during-covid-19.
• 11. Grant J, Wilmore S, McCann N, Donnelly O, Lai R, Kinsella M, et al. Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a London NHS Trust. Infect Control Hosp Epidemiol. 2021; 42(2):212-214.
• 12. Arslan GK, Özdemir M, Kaya H, Feyzioğlu B, Kepenek Kurt E, Erayman İ. Bir üniversite hastanesi sağlık çalışanlarında COVID-19 seroprevalansı. FLORA. 2021; 26(3):384-91.
• 13. Team E. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020. China CDC weekly. 2020; 2(8):113.
• 14. Zhang Z, Liu S, Xiang M, Li S, Zhao D, Huang C, et al. Protecting healthcare personnel from 2019-nCoV infection risks: lessons and suggestions. Front Med. 2020: 14(2):229-231.
• 15. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama. 2020; 323(11):1061-9.
• 16. Seyhan AU, Karaca B. Kuzeybatı Suriye Bölgesi’nde COVID-19 saptanan sağlık çalışanlarının demografik ve klinik özelliklerinin değerlendirilmesi. Turk Hij Den Biyol Derg. 2021; 78(1):39-46.
• 17. Pala SÇ, Metintaş S. COVID-19 Pandemisinde Sağlık Çalışanları. ESTÜDAM Halk Sağlığı Dergisi. 2020; 5(COVID-19 Özel Sayısı):156-68.
• 18. Iversen K, Bundgaard H, Hasselbalch RB, Kristensen JH, Nielsen PB, Pries-Heje M, et al. Risk of COVID-19 in health-care workers in Denmark: an observational cohort study. Lancet Infect Dis. 2020; 20(12):1401-1408.
• 19. S Mandić-Rajčević S, F Masci, E Crespi, S Franchetti, A Longo, I Bollina, et al. Source and symptoms of COVID-19 among hospital workers in Milan. Occup Med (Lond). 2020; 70(9):672-679.
• 20. Gómez-Ochoa SA, Franco OH, Rojas LZ, Raguindin PF, Roa-Díaz ZM, Wyssmann BM, et al. COVID-19 in health-care workers: a living systematic review and meta-analysis of prevalence, risk factors, clinical characteristics, and outcomes. Am J Epidemiol. 2021; 190(1):161-175.
• 21. Jiang F, Deng L, Zhang L, Cai Y, Cheung CW, Xia Z. Review of theclinical characteristics of coronavirus disease 2019 (COVID‐19). J Gen Intern Med. 2020; 35(5):1545‐1549.
• 22. Gao Z, Xu Y, Sun C, Wang X, Guo Y, Qiu S, et al. A systematic review of asymptomatic infections with COVID-19. J Microbiol Immunol Infect. 2021; 54(1):12-16.
• 23. Nishiura H, Kobayashi T, Miyama T, Suzuki A, Jung SM, Hayashi K, et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis. 2020;94:154–5.
• 24. Yang R, Gui X, Xiong Y. Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China. JAMA. 2020;3(5):2010182.
• 25. Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill. 2020; 25(10): 2000180.
• 26. Sims MD, Maine GN, Childers KL, Podolsky RH, Voss DR, Berkiw-Scenna N, et al. Coronavirus disease 2019 (COVID-19) seropositivity and asymptomatic rates in healthcare workers are associated with job function and masking. Clin Infect Dis. 2021; 73(Supplement_2):154-162.
• 27. Tan JY, Sim XYJ, Wee LE, Chua YY, Cherng BPZ, Ng IM, et al. A comparative study on the clinical features of COVID‐19 with non‐SARS‐CoV‐2 respiratory viral infections. J Med Virol. 2021; 93(3):1548-1555.
• 28. Sümer Ş, Ural O, Aktuğ-Demir N, Cifci S, Turkseven B, Kilincer A, et al. Clinical and laboratory characteristics of COVID-19 cases followed in Selçuk University Faculty of Medicine. Klimik Derg. 2020;33(2):122-7.
• 29. Zhang ZL, Hou YL, Li DT, Li FZ. Laboratory findings of COVID-19: a systematic review and meta-analysis. Scand J Clin Lab Invest. 2020;80(6):441-447.
• 30. Krishnan A, Hamilton JP, Alqahtani SA, A Woreta T. A narrative review of coronavirus disease 2019 (COVID-19): clinical, epidemiological characteristics, and systemic manifestations. Intern Emerg Med 2021;16(4):815-830.